3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
66
Carcinoma, Renal Cell
38
Liver Neoplasms
20
Neoplasm Metastasis
17
Carcinoma, Non-Small-Cell Lung
16
Neoplasms
15
Breast Neoplasms
15
Melanoma
13
Thyroid Neoplasms
10
Leukemia, Myeloid, Acute
10
Sarcoma
9
Lung Neoplasms
8
Kidney Neoplasms
8
Prostatic Neoplasms
7
Ovarian Neoplasms
7
Urinary Bladder Neoplasms
6
Pancreatic Neoplasms
6
Glioblastoma
6
Brain Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Medullary
5
Thyroid Carcinoma, Anaplastic
4
Stomach Neoplasms
4
Rectal Neoplasms
4
Gliosarcoma
4
Gallbladder Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms, Male
4
Thyroid Diseases
3
Thyroid Cancer, Papillary
3
Interventions
lenvatinib
1
adefovir
1
Ultrasonography
1
Sorafenib
1
PHY 906
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hepatitis B
×
Sorafenib
×
Clear all
NCT04710641
2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2
Completed
8 enrolled